• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Shares of pharmaceutical giant Merck rose slightly Monday morning after President Trump slammed high drug prices in response to the company's CEO resigning from the White House's manufacturing council. (AP Photo/Mel Evans)
    Healthcare

    The Trump bump: Merck shares rise after tweet

    Kimberly Leonard -
    August 14, 2017 3:15 pm
    0
    News

    Trump slams Merck’s ‘ripoff drug prices’ after CEO resigns from manufacturing council

    Melissa Quinn -
    August 14, 2017 1:11 pm
    0
    New Hampshire on Tuesday became the latest state to launch a lawsuit against a prescription painkiller manufacturer, Perdue Pharma, for deceptively marketing OxyContin. (AP Photo/Toby Talbot, File)
    Healthcare

    New Hampshire sues opioid makers for deceptive marketing

    Kimberly Leonard -
    August 9, 2017 3:39 pm
    0
    Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)
    Crime

    Martin Shkreli leaves a legacy on Capitol Hill

    Robert King -
    August 5, 2017 12:22 am
    0
    ‘Pharma Bro’ Martin Shkreli found guilty of securities fraud
    Healthcare

    ‘Pharma Bro’ Martin Shkreli found guilty of securities fraud

    Robert King -
    August 4, 2017 6:52 pm
    0
    The bill reauthorizes the FDA's program through which it charges fees for new drug or device applications. (iStock photo)
    Healthcare

    Senate passes FDA funding package

    Robert King -
    August 3, 2017 4:47 pm
    0
    The bill would allow terminally ill patients the right to try experimental treatments that have not been approved when no alternatives exist. (iStock photo)
    Healthcare

    Senate passes bill to give terminally ill patients access to experimental drugs

    Robert King -
    August 3, 2017 4:18 pm
    0
    Premiums for Medicare's Part D prescription drug program are expected to slightly decline in 2018, the first drop in five years, the Trump administration said Wednesday. (AP Photo/Jon Elswick)
    Healthcare

    Medicare Part D premiums set to drop next year

    Robert King -
    August 2, 2017 9:43 pm
    0
    It is clear that neither party is willing to work with the other in order to create a better healthcare alternative. All the while, patients are suffering -- limited access and expensive premiums have isolated many. (C-SPAN2 via AP)
    Beltway Confidential

    Broken promises: Congress has let down patients and doctors in failing to fix Obamacare

    Kevin Campbell -
    July 25, 2017 9:50 pm
    0
    Rather than giving companies new tax breaks or a cut in their overall tax rate, the focus of tax reform should be to completely clean out the code of all the special interest tax breaks and loopholes that companies such as Mylan take advantage of. (Victor J. Blue/Bloomberg)
    Business

    Mylan: The poster child of what is wrong with the tax code

    Washington Examiner Staff -
    July 24, 2017 4:01 am
    0
    1...110111112...159Page 111 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.